Bayer AG (OTC:BAYRY) – Investment analysts at Jefferies Group issued their Q3 2016 EPS estimates for shares of Bayer AG in a research note issued on Thursday. Jefferies Group analyst J. Holford anticipates that the firm will post earnings per share of $1.78 for the quarter. Jefferies Group also issued estimates for Bayer AG’s FY2017 earnings at $8.83 EPS.

Earnings History and Estimates for Bayer AG (OTC:BAYRY)

Separately, Citigroup Inc. raised Bayer AG from a “neutral” rating to a “buy” rating in a research report on Thursday, August 25th.

Bayer AG (OTC:BAYRY) opened at 99.33 on Monday. The company has a market capitalization of $82.14 billion, a price-to-earnings ratio of 16.37 and a beta of 1.35. Bayer AG has a 52-week low of $94.36 and a 52-week high of $135.71. The company’s 50-day moving average price is $103.03 and its 200 day moving average price is $106.34.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

Bayer AG Company Profile

Bayer AG is a Germany-based chemical and pharmaceutical company. The Company’s business operations are organized into three segments: Bayer HealthCare, Bayer CropScience and Bayer MaterialScience, supported by the service companies Bayer Business Services, Bayer Technology Services and Currenta. Bayer HealthCare researches, develops, manufactures and markets products to improve the health of people and animals.

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with's FREE daily email newsletter.